E

Exact Sciences Corp
D

EXAS

54.780
USD
0.52
(0.96%)
مغلق
حجم التداول
130,506
الربح لكل سهم
-0
العائد الربحي
-
P/E
-47
حجم السوق
10,138,479,331
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ALGN
    4.180
    (1.83%)
    232.180 USD
    ILMN
    ILMN
    -1.005
    (-0.71%)
    140.300 USD
    ISRG
    ISRG
    6.68
    (1.11%)
    610.50 USD
    N
    NVCR
    -0.110
    (-0.41%)
    26.830 USD
    P
    PODD
    2.66
    (0.96%)
    278.79 USD
    R
    RGEN
    -1.170
    (-0.70%)
    166.730 USD
    T
    TDOC
    0.38500
    (4.06%)
    9.87500 USD
    T
    TECH
    -0.030
    (-0.04%)
    78.720 USD
    V
    VEEV
    5.920
    (2.65%)
    229.110 USD
    المزيد
الأخبار
المقالات

العنوان: Exact Sciences Corp

القطاع: Healthcare
الصناعة: Diagnostics & Research
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a precancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.